B-cell maturation antigen (BCMA)-directed bispecific antibodies have tolerable safety profiles in frail patients with relapsed/refractory multiple myeloma (MM), according to a real-world study ...

Recent novel treatments for chronic lymphocytic leukemia (CLL), such as second-generation covalent Bruton tyrosine kinase inhibitors (cBTKis) and venetoclax-obinutuzumab (VenO), may offer better ...

Tumor burden score predicted survival in patients with a performance status of 0; only a high TBS predicted survival with a PS of 1 or 2.

These results may help guide management strategies and prognostication among patients with advanced NSCLC who experience severe irAE and in whom permanent ICI discontinuation is required,” the ...